论文部分内容阅读
目的探究干扰素联合炎琥宁治疗小儿手足口病的临床效果。方法将该院于2015年3月-2016年3月收治的86例手足口病患儿随机分成2组,各43例;对照组给予常规治疗,观察组给予干扰素联合炎琥宁联合治疗,对比两组临床治疗效果。结果在治疗总有效率上,观察组为95.35%,与对照组69.77%相比明显更高(P<0.05)。观察组住院时间、临床症状消失时间与对照组相比明显更短(P<0.05)。在不良反应发生率上,观察组为18.60%,与对照组2.33%相比明显更低(P<0.05)。结论手足口病患儿给予干扰素及炎琥宁联合治疗效果显著,值得在临床治疗中推广及使用。
Objective To investigate the clinical effect of interferon combined with midazolam in the treatment of hand-foot-mouth disease in children. Methods 86 cases of hand, foot and mouth disease admitted to our hospital from March 2015 to March 2016 were randomly divided into two groups (43 cases each). The control group was given routine treatment. The observation group was treated with interferon combined with mesylate. Comparison of two groups of clinical treatment. Results The total effective rate in the observation group was 95.35%, which was significantly higher than that in the control group (69.77%) (P <0.05). The length of hospital stay and the disappearance of clinical symptoms in the observation group were significantly shorter than those in the control group (P <0.05). The incidence of adverse reactions, the observation group was 18.60%, compared with 2.33% in the control group was significantly lower (P <0.05). Conclusion The treatment of HFMD in children with HFMD is significant and worthy of promotion and use in clinical treatment.